Trial Profile
Feasibility study of outpatient chemotherapy with S-1+CDDP in gastric cancer patients.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 07 Nov 2009 New trial record